Biotech

All Articles

F 2G rears $100M for second attempt to receive brand new antifungal to market

.After F2G's first attempt to get a new training class of antifungal to market was derailed by the F...

Moderna targets $1.1 B in R&ampD spending slices, drops 5 courses surrounded by success stress

.Moderna has actually sworn to reduce R&ampD spending through $1.1 billion by 2027. The decision to ...

Sanofi's $80M bet on Fulcrum dystrophy drug ends in period 3 fail

.Simply four months after Sanofi bet $80 thousand in beforehand cash on Key Rehabs' losmapimod, the ...

Oncternal assets drains 60% among unemployments, trial firings

.Cancer cells firm Oncternal Rehabs is actually folding all its professional tests as well as giving...

Roche is actually keeping out hopes that its injectable being overweight prospect can at some point show 25% fat loss in late-stage trial

.Roche is holding out hopes that its own injectable weight problems prospect can ultimately demonstr...

Novo Nordisk barrages 'outstanding' weight-loss result for dual-acting dental medication in early trial

.Novo Nordisk has actually raised the cover on a stage 1 test of its own dental amylin and also GLP-...

AbbVie sues BeiGene over blood stream cancer medication classified information

.Just a couple of quick full weeks after gaining an FDA Fast Track tag for its investigational BTK d...

Lilly provides one-two punch along with 2nd tranche of beneficial information on regular the hormone insulin candidate

.Shortly after a positive information decline for Eli Lilly's efsitora alfa, the Indianapolis-based ...

BridgeBio reduces genetics therapy budget as clinical records let down

.BridgeBio Pharma is lowering its own gene therapy budget plan and also pulling back coming from the...

GSK gives up HSV injection really hopes after phase 2 fall short, resigning ethnicity to Moderna, BioNTech

.GSK's effort to cultivate the 1st vaccination for herpes simplex infection (HSV) has actually finis...